AbbVie Reports Third-Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Wall St futures tick higher as oil retreats ahead of inflation data
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
AbbVie (ABBV) Tops Q3 EPS by 3c, Lifts FY EPS Guidance
October 27, 2017 7:42 AM EDTAbbVie (NYSE: ABBV) reported Q3 EPS of $1.41, $0.03 better than the analyst estimate of $1.38. Revenue for the quarter came in at $7 billion versus the consensus estimate of $7 billion.
GUIDANCE:
AbbVie sees FY2017 EPS of $5.53-$5.55, versus the consensus of $5.53.
Update To... More
